In the fight against fatty liver disease, researchers are looking for any and all possible solutions. But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists must first understand how the liver metabolizes fat. MASLD is on the rise in the U.S., now affecting nearly 40% of adults. The condition occurs when the body deposits extra fat in the liver, leading to inflammation, fibrosis and, in some cases, permanent liver damage or liver cancer.
This article was originally published on MedicalXpress.com
